2m 2m 2m 2m 2m 2m 2m
DESIGN THERAP (DSGN)
NASDAQ
$12.36+$0.12 (+0.94%)
Price as of Oct 02, 2026 4:10 PM EDT- $766.0MMarket Cap
- 103.49%1-Year Change
- BiotechnologyIndustry
DESIGN THERAP (DSGN)
$12.36+$0.12 (+0.94%)
DSGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.24 | ||
Change | -$0.33 (-2.63%) | ||
Open | $12.50 | ||
High | $12.82 | ||
Low | $12.21 | ||
Previous Close | $12.57 | ||
Volume | 346,590 | ||
30-Day Average Volume | 746,557 | ||
1-Week Change | 0.00% | ||
1-Month Change | -19.15% | ||
1-Year Change | 103.49% | ||
3-Year Change | 418.64% | ||
5-Year Change | -18.35% | ||
Fundamentals | |||
Shares Outstanding | 62.6M | ||
Total Assets | $215.1M | ||
Market Cap | $766.0M | ||
Enterprise Value | $753.1M | ||
Period: QTR TTM FY | |||
Revenue | $2.0M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$15.5M | ||
EBIT | -$20.2M | ||
EBITDA | -$20.0M | ||
Net Working Capital | $200.8M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | 374 | ||
P/B | 4 | ||
P/E | -38 | ||
PEG | 4 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue